Official recall notice

FDA DrugClass IINotable

Ranolazine Extended-Release Tablets Recall (Oct 2026)

Product: Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

Recall date
2026-10-07
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Failed Dissolution Specifications: below specification

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Failed Dissolution Specifications: below specification

Affected products

Lot: DJ25134, Exp 11/30/2028

Verify with the official notice →
Share:

Related Recalls

2026-09-16 · FDA_DRUG
FDA Recall: Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles, Rx Only, Marketed by: Ajanta Pharm
Ajanta Pharma USA Inc
2026-07-01 · FDA_DRUG
FDA Recall: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, Ind
Ajanta Pharma USA Inc
2026-06-24 · FDA_DRUG
FDA Recall: Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pharma USA Inc., Bridgewat
Ajanta Pharma USA Inc